TG Therapeutics Inc (STU:NKB2)
€ 49.4 +2.6 (+5.56%) Market Cap: 7.52 Bil Enterprise Value: 7.73 Bil PE Ratio: 19.51 PB Ratio: 14.65 GF Score: 82/100

TG Therapeutics Inc (STU:NKB2) Transcripts

  • 1